| Vol. 12.44 – 9 November, 2021 |
| |
|
|
| Researchers developed a technique that combined mosaic mutagenesis with color labeling of hematopoietic stem and progenitor cells to study how acquired mutations affected clonal fitness in a native environment. [Science] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists reported overexpression of human mature T cell proliferation 1 gene (MTCP1) restricted to the B cell compartment in mice produced a clonal CD5+/CD19+ leukemia recapitulating the major characteristics of human chronic lymphocytic leukemia. [Nature Communications] |
|
|
|
| The authors discovered that FMS-like Tyrosine Kinase 3 (FLT3)-internal tandem duplication (ITD) directly bound to CSF2RB in acute myeloid leukemia (AML) cell lines and blasts isolated from AML patients. [Leukemia] |
|
|
|
| Investigators found that CD109 suppressed TGF-β signaling in hematopoietic stem progenitor cells (HSPCs), and increased the sensitivity of PIGA-mutated HSPCs to TGF-β, leading to the preferential commitment of erythroid progenitor cells to mature red blood cells. [Leukemia] |
|
|
|
| To obtain a comprehensive picture of composite genetic driver events and clonal dynamics in subtypes of pediatric acute lymphoblastic leukemia, scientists analyzed tumor-normal whole genome sequencing and expression data from 361 newly diagnosed patients. [Blood Cancer Journal] |
|
|
|
| The authors showed that, unlike normal B cells, diffuse large B cell lymphoma (DLBCL) cells expressed abundant levels of transducin b-like protein 1 and its overexpression correlated with poor clinical outcome regardless of DLBCL molecular subtype. [Haematologica] |
|
|
|
| Scientists discovered that the T-complex protein 1 (TCP1) expression was elevated in acute myeloid leukemia patients and high TCP1 expression was associated with low complete response rate along with poor overall survival. [Cell Death & Disease] |
| |
|
|
| Clonal hematopoiesis of indeterminate potential (CHIP) is a novel age-related risk factor for cardiovascular disease–related morbidity and mortality. Researchers found that CHIP was associated with an increased risk of stroke, particularly with hemorrhagic and small vessel ischemic stroke. [Stroke] |
|
|
|
| The authors evaluated long-term outcomes in 40 patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML), transplanted from related or unrelated donors following conditioning with targeted busulfan, fludarabine, and thymoglobulin. [Bone Marrow Transplantation] |
|
|
|
|
| Scientists highlight interesting parallels between endothelial-to-hematopoietic transition and endothelial-to-mesenchymal transition, which occurs during cardiac development. [Genes & Development] |
|
|
|
|
| Jasper Therapeutics, Inc. announced that it has entered into a non-exclusive research collaboration with AVROBIO, Inc. to evaluate the use of JSP191, Jasper’s anti-CD117 monoclonal antibody, as a targeted conditioning agent option for patients with Fabry disease and/or Gaucher disease type 1. [Jasper Therapeutics, Inc.] |
|
|
|
| Cyclacel Pharmaceuticals, Inc. announced dosing of the first patient in the company’s multi-cohort Phase I/II study of oral fadraciclib in patients with leukemias or myelodysplastic syndromes. [Cyclacel Pharmaceuticals, Inc.] |
|
|
|
|
| December 8 – 11, 2021 Geneva, Switzerland |
|
|
|
|
|
| Dana-Farber Cancer Institute – Boston, Massachusetts, United States |
|
|
|
| University Children’s Hospital Zurich – Zurich, Switzerland |
|
|
|
| Icahn School of Medicine at Mount Sinai – New York, New York, United States |
|
|
|
| Boston Children’s Hospital – Boston, Massachusetts, United States |
|
|
|
| University of Manitoba – Winnipeg, Manitoba, Canada |
|
|
|
|